Exclusion of Patients with Autoimmune Disease in Lung Cancer Clinical Trials

BACKGROUND: The exclusion of patients with autoimmune disease has been a topic of cancer immunotherapy trial. This study aims to find recent trends in exclusion of autoimmune disease. METHODS: Using the website clinicaltrials.gov, we searched for clinical trials that were initiated in 2012 or later...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Shamsher S, Komiya, Takefumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152841/
https://www.ncbi.nlm.nih.gov/pubmed/36708584
http://dx.doi.org/10.31557/APJCP.2023.24.1.331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152841/
https://www.ncbi.nlm.nih.gov/pubmed/36708584
http://dx.doi.org/10.31557/APJCP.2023.24.1.331

Ejemplares similares